English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The ways in which race, ethnicity, and ancestry are used and reported inhuman genomics research has wide-ranging implications for how research istranslated into clinical care, incorporated into public understanding, andimplemented in public policy. Genetics researchers play an essential role inproactively dismantling genetic conceptions of race and in recognizing thesocial and structural factors that drive health disparities. Here, we offercommentary and concrete recommendations on the use and reporting of race,ethnicity, and ancestry across the arc of genetic research, includingterminology, data harmonization, analysis, and reporting. While informed by ourexperiences as researchers in the NHLBI Trans-Omics for Precision Medicine(TOPMed) program, the recommendations are broadly applicable to basic andtranslational genomic research in diverse populations. To fully realize thebenefit of diversifying genetics research beyond primarily European ancestrypopulations, we as genetics researchers need to make structural changes to theresearch process and within the research community. Considerable collaborativeeffort and ongoing reflection will be required to root out elements of racismfrom the field and generate scientific knowledge that yields broad andequitable benefit.

Recommendations on the use and reporting of race, ethnicity, and  ancestry in genetic research: experiences from the NHLBI Trans-Omics for  Precision Medicine (TOPMed) program